查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1526347

全球数位疗法市场

Digital Therapeutics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 326 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球数位治疗市场预计将达到 329 亿美元

全球数位治疗市场预计 2023 年为 57 亿美元，预计到 2030 年将达到 329 亿美元，2023-2030 年分析期间复合年增长率为 28.6%。治疗/护理应用是本报告分析的细分市场之一，预计复合年增长率为 29.1%，到分析期结束时将达到 281 亿美元。分析期内，预防性应用领域的复合年增长率预计为 26.0%。

美国市场预计23亿美元，中国预计复合年增长率32.2%

预计 2023 年美国数位治疗市场价值将达到 23 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达32亿美元，2023-2030年分析期间复合年增长率为32.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 25.4% 和 23.6%。在欧洲，德国预计复合年增长率为 28.5%。

全球数位治疗市场 - 主要趋势和驱动因素总结

数位治疗 (DTx) 是医疗保健行业的一个变革部分，专注于透过软体程式提供基于证据的治疗性介入，以预防、管理和治疗医疗状况。这些治疗性介入通常透过行动应用程式、数位设备和线上平台提供，旨在与传统治疗一起或单独使用。数位治疗利用行为科学、人工智慧和资料分析来提供个人化治疗计划、即时监测患者进展并提供回馈以改善健康结果。临床检验是数位疗法的基石，确保这些解决方案符合与传统药物相当的严格的功效和安全标准。

数位疗法可治疗多种疾病，包括糖尿病和高血压等慢性疾病，以及焦虑和忧郁症等精神疾病。透过将数位工具整合到传统医疗保健中，DTx 解决方案可以提供持续监测和即时干预措施，这对于有效管理慢性病至关重要。这些解决方案还使患者能够更好地控制自己的健康，从而提高患者的参与度并提高对治疗计划的依从性。此外，数位疗法可以弥合获得医疗保健的差距，并透过可扩展、经济高效且易于访问的数位平台为服务不足的人群提供支援。游戏化和使用者友善介面的结合进一步提高了患者的参与度和依从性，使个人更容易遵守治疗计划。

数位治疗市场的成长受到多种因素的推动。数位疗法主要是由慢性病盛行率不断上升和个人化医疗需求不断增加所推动的，因为它提供了量身定制的干预措施，可以显着改善患者的治疗效果。人工智慧、机器学习和行动医疗技术的进步正在增强 DTx 解决方案的功能和范围，使其更加有效和用户友好。消费行为也是一个关键驱动因素，患者越来越习惯使用数位健康工具并寻求主动的健康管理。医疗保健提供者和保险公司对数位疗法的监管支持和认可证明了 DTx 解决方案的有效性和可靠性，进一步推动了市场的发展。此外，COVID-19 大流行加速了数位医疗技术的采用，凸显了远距医疗解决方案的重要性，并增加了对数位治疗领域的投资。总的来说，这些因素促进了医疗保健领域数位疗法的强劲成长和更多采用。

受访企业范例（共136家）

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP11567

Global Digital Therapeutics Market to Reach US$32.9 Billion by 2030

The global market for Digital Therapeutics estimated at US$5.7 Billion in the year 2023, is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 28.6% over the analysis period 2023-2030. Treatment / Care Application, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$28.1 Billion by the end of the analysis period. Growth in the Preventive Application segment is estimated at 26.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 32.2% CAGR

The Digital Therapeutics market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 32.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.4% and 23.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.5% CAGR.

Global Digital Therapeutics Market - Key Trends & Drivers Summarized

Digital Therapeutics (DTx) represents a transformative segment of the healthcare industry, focusing on delivering evidence-based therapeutic interventions through software programs to prevent, manage, or treat medical conditions. These interventions are often delivered via mobile apps, digital devices, and online platforms, and are designed to be used independently or alongside traditional medical treatments. Digital therapeutics leverage behavioral science, artificial intelligence, and data analytics to provide personalized treatment plans, monitor patient progress in real-time, and offer feedback to improve health outcomes. Clinical validation is a cornerstone of digital therapeutics, ensuring that these solutions meet rigorous standards of efficacy and safety comparable to traditional pharmaceuticals.

Digital therapeutics address a wide range of conditions, including chronic diseases like diabetes, hypertension, and mental health disorders such as anxiety and depression. By integrating digital tools with traditional healthcare, DTx solutions can offer continuous monitoring and real-time interventions, which are crucial for managing chronic diseases effectively. These solutions also empower patients by giving them greater control over their health, enhancing engagement and adherence to treatment plans. Additionally, digital therapeutics can bridge gaps in healthcare access, providing support to underserved populations through scalable, cost-effective, and easily accessible digital platforms. The incorporation of gamification and user-friendly interfaces further enhances patient engagement and compliance, making it easier for individuals to stick to their therapeutic regimens.

The growth in the digital therapeutics market is driven by several factors. The increasing prevalence of chronic diseases and the rising demand for personalized medicine are primary drivers, as digital therapeutics offer tailored interventions that can significantly improve patient outcomes. Technological advancements in AI, machine learning, and mobile health technologies are enhancing the capabilities and reach of DTx solutions, making them more effective and user-friendly. Consumer behavior is also a significant driver, with patients becoming more comfortable using digital health tools and seeking proactive management of their health. Regulatory support and the recognition of digital therapeutics by healthcare providers and insurers are further propelling the market, as these endorsements validate the efficacy and reliability of DTx solutions. Additionally, the COVID-19 pandemic has accelerated the adoption of digital health technologies, highlighting the importance of remote healthcare solutions and increasing investment in the digital therapeutics sector. These factors collectively contribute to the robust growth and expanding adoption of digital therapeutics in the healthcare landscape.

Select Competitors (Total 136 Featured) -

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Digital Therapeutics is Poised to Benefit from the Increasingly Robust Outlook for Digital Health
    • Digital Healthcare Sets the Stage for the Rise of Digital Therapeutics: Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
    • Global Economic Update
    • Competition
    • Digital Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Digital Therapeutics: Overview & Market Outlook
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Global Focus on Meeting Unmet Needs in Mental Healthcare to Benefit Growth of Digital Therapeutics
    • Shockingly High Burden of Mental Disorders & the Ensuing Focus to Meet Unmet Care Needs Primes Digital Therapeutics for Mass Adoption: Global Economic Cost of Mental Illnesses (In US$ Trillion) for Years 2023, 2025, 2027, 2029 & 2031
    • Artificial Intelligence to Play a Key Role in Improving the Effectiveness of Digital Therapeutics
    • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
    • Rising Prevalence of Chronic Diseases Amplifies the Need for Addressing Management of These Diseases Through Digital Therapeutics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
    • Here's How Digital Therapeutics Can Help Improve Clinical Outcomes Across the Cardiac Continuum
    • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
    • How Digital Therapeutics is Changing the Oncology Care Landscape?
    • Worrisome Epidemic Increase in Cancer Incidence to Help Accelerate Adoption of Digital Therapeutics: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rise of mHealth & Smart Medical Devices & Wearables Paves the Way for More Spontaneous Adoption of Digital Therapeutics
    • Growing Familiarity with mHealth & Use of Medical Wearables Means There is One Less Obstacle in the Implementation of Digital Therapeutics: Global Market for mHealth & Medical Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 2031
    • As Healthcare Costs Continue to Spiral, Growing Much Faster Than National GDP, Focus Shifts to Digital Therapeutics for its Ability to Lower Cost of Care
    • Growing Urgency to Rein-in Spiraling Healthcare Costs Leads Healthcare Community to Take a Closer Look at Digital Therapeutics: Healthcare Costs as a % of GDP by Country 2020 VS 2023
    • Growing Preference for Personalized Medicine Doubles the Focus on Digital Therapeutics
    • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Digital Therapeutics: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
    • Here's How AR/VR Technologies are Changing the Future of Digital Therapeutics
    • The Many Benefits of 5G in Healthcare to Catalyze Adoption of Digital Therapeutics
    • Rapid Penetration of 5G Will Make Implementation of Digital Therapeutics Seamless & More Efficient to Use: Global 5G Subscription (In Million) for Years 2023, 2025, 2027 and 2029
    • Technology and Innovation to Continue to Drive Adoption of Digital Therapeutics
    • Cybersecurity Storms Into the Spotlight. Here's Why
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Treatment / Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Treatment / Care by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 13: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • JAPAN
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • CHINA
    • TABLE 24: China Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • EUROPE
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • FRANCE
    • TABLE 34: France Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • GERMANY
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • UNITED KINGDOM
    • TABLE 46: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030

IV. COMPETITION